TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: mean pupillary diameter post-phacoemulsification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in beta 2-sympathomimetic inhalation therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Levels of IL-1β and RANK-L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean logMAR BCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean CFT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean aqueous VEGF concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oversedation
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in audiometric test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time above the minimum inhibitory concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulty of cannulation of a distal segment of the obliterated vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ease of delivery of a working part to the SFJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visualization of the working tip at the SFJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: visual acuity decline of two or more lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stinging after lens insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Night/day systolic BP ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Night/day diastolic BP ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in clinical parameters scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in IL-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Target extremity major amputation
Endpoint domain: Mortality/survival
Primary endpoint: Patency loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Higher comorbidity (ICED scores > or =2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Karnofsky Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in TOI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean change from baseline in FACT-B total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Consecutive weeks of cannabis abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tobacco abstinence for at least two consecutive weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in tobacco use (cigarettes per day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IKDC subjective knee evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean PFG clearance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infectivity rate of PFG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Nursing facility use
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: incidence of upper GI tract events
Endpoint domain: Adverse events/effects
Primary endpoint: rewarming time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rewarming efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidences of arrhythmia and shivering
Endpoint domain: Adverse events/effects
Primary endpoint: MRD negativity at end-induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: palatability score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preparations scored as excellent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nausea incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of unexpected clinically significant primary and secondary diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation as an adverse effect
Endpoint domain: Adverse events/effects
Primary endpoint: Wellbeing and performance of daily activities
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Complete response rate to PDL treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean clinical tumor diameter of complete responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Residual histologic tumor burden after PDL treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: beta(2)-microglobulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma non-refilling ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle cramps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean catheter times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative dysuria scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability associated with back pain (RDQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sickness absence due to musculoskeletal conditions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sensory and motor block differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal percentage increase in platelet concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Relative dose intensity for combination chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of infection at 6 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: average volume of voided urine per micturition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: percentage of patients with positive cultures of AGNB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: ESA resistance index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive improvements in memory and executive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in social activity scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: feasibility of transnasal insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tolerance of EGD
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: acceptation of a new EGD
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Death during the 90 days after treatment
Endpoint domain: Mortality/survival
Primary endpoint: Serious adverse event reports
Endpoint domain: Adverse events/effects
Primary endpoint: Barthel Index greater than 60 in TACS subgroup
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum distance walked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sinus rhythm maintenance after a single procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrence rate of atrial tachycardia (AT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Utilization of preventive dental services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Apo-B concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Apo-B/Apo-A-1 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Transfer rates of lipids to HDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscle protein synthesis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-sec chair stand performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: arm curls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grip-strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Icotinib pharmacokinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioavailability increase with food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Influence of age, albumin concentration, and CYP2C19 genotype on pharmacokinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain-free subjects after two weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity score decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in body fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level during swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iron balance restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in storage iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SSES scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Days lost due to heart failure readmissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse events related to investigational treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in Treg response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ADC value change after chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost to avoid one cardiovascular event or procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost to gain one quality‐adjusted life‐year
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of peanut allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cumulative hematologic toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: cumulative neurologic toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurological deterioration
Endpoint domain: Adverse events/effects
Primary endpoint: Device-related neurological adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Device-related subsequent surgeries
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Placement in residential care
Endpoint domain: Mortality/survival
Primary endpoint: Psychological health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sleep promotion
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Quit rate at Week 26
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of anal fissures
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenic response to NIKS keratinocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: False Positive Rate (FPR) in screening for trisomy 21
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c at 1 year postsurgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of LGA babies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total maternal weight gain during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum levels of vitamin C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum levels of vitamin E
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum levels of beta-carotene
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum levels of selenium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VO2 peak value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance covered in the 6-minute walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC physical function score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Steroid cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final steroid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in steroid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of self-stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement of self-esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: wound site complications
Endpoint domain: Adverse events/effects
Primary endpoint: Improved knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement in clinical reasoning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Enhanced understanding of surgical technique and anatomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Allergic reactions to moist toilet paper
Endpoint domain: Adverse events/effects
Primary endpoint: Perianal dermatitis disappearance after discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Initiation of smoking cessation treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perception of worsening symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: surgical avoidance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Down-regulation of proinflammatory S100 proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD4 T cell count increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ki67-proliferating CD4 increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD4 TREC increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of postoperative atrial fibrillation (AF)
Endpoint domain: Mortality/survival
Primary endpoint: Sympathetic activity (norepinephrine and epinephrine levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 3-h postprandial glucose area under the curve (>160 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: long-term exercise adherence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: gains in online awareness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Aβ deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VTE complications
Endpoint domain: Adverse events/effects
Primary endpoint: D28 PCR-corrected cure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug-induced vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Total bilirubin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Aminotransferases levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Gamma glutamyl transpeptidase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Alkaline phosphatase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Vertebral bone density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adenoma Detection Rate (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: OFDI-derived late lumen area loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores of symptom-sign
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee joint function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Blood glucose levels under 200 mg/dl postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Median time to treatment with analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: obstructions induced by blood clot
Endpoint domain: Adverse events/effects
Primary endpoint: complications attributed to the mini-catheter
Endpoint domain: Adverse events/effects
Primary endpoint: Convergent validity of EQ-5D-3L
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Exercise capacity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of incorrect hand placements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of placental-mediated complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: satisfactory outcome in physical functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Survival to 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Surviving without severe disability
Endpoint domain: Mortality/survival
Primary endpoint: Mean wheezing score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean retraction score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean air-bone gap closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of maternal, neonatal and young infant GBS disease
Endpoint domain: Mortality/survival
Primary endpoint: Body weight ratio changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lean body weight changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural amnesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Controlling behaviour during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes distress (PAID score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-efficacy (DES score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: A1C trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PFF (Percentage of Fat Fraction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: endurance parameter on extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: number of respiratory infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: headache response 4 hours postdose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum serum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: prolongation of the PR intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fear of Falling (FOF)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Use of topical and oral medications to manage teething problems
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of self-reported food allergy (FA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of cellular proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of early-stage breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: 3-year risk of major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Number of text messages composed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants' evaluation of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increased elastin density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Coefficient of failure from HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes